4.8 (269) In stock
SARS-CoV-2 Proteins
Recombinant Anti-SARS-CoV-2 Spike Glycoprotein S1 antibody [CR3022] (ab273073)
タンパク質発現システム
Top: Design elements found in synthetic mRNA therapeutics. Bottom
Nuclear translocation of spike mRNA and protein is a novel pathogenic feature of SARS-CoV-2
ACE2 Expression Lentivector
Host cell entry mediators implicated in the cellular tropism of SARS‑CoV‑2, the pathophysiology of COVID‑19 and the identification of microRNAs that can modulate the expression of these mediators (Review)
Frontiers The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens
SARS-CoV-2 S protein (RBD, 319-541 aa) antibody (67758-1-Ig)
SARS-CoV-2 / COVID-19 Antibodies, Proteins, Kits
Recombinant Anti-SARS-CoV-2 Spike Glycoprotein S1 antibody [CR3022] (ab273073)
S SARS-CoV-2 Spike Glycoprotein mRNA (20 ug, Transfection-ready)
S SARS-CoV-2 Spike Glycoprotein mRNA (20 ug, Transfection-ready) | CVD19-435A-1
PDB-101: Learn: Resources to Fight the COVID-19 Pandemic: SARS-CoV-2 mRNA Vaccine
